Markets

Insider Trading

Hedge Funds

Retirement

Opinion

1281292 - 11759070 - 1

8 Most Promising Robotics Stocks Now

Page 1 of 2

In this piece, we will discuss the 8 Most Promising Robotics Stocks Now.

The robotics boom is no longer a distant prediction. Robotics adoption is accelerating across industries, driven by advances in artificial intelligence, automation, and sensing technologies. As companies invest in greater efficiency and autonomy, investors are increasingly looking for stocks that could benefit from these long-term trends.

On June 3, 2026, CNBC reported that SoftBank CEO Masayoshi Son identified physical AI and robotics as the space most likely to produce the next trillion-dollar company. That same week, Zornitza Todorova, head of thematic FICC research at Barclays, told CNBC’s Squawk Box Europe that the humanoid robotics market, currently worth just $2 to $3 billion, is on track to reach $200 billion by 2035, calling this “the decade of the robot.”

The forecasts are already accelerating. On June 24, 2026, CNBC reported that Morgan Stanley had sharply upgraded its China humanoid shipment forecast for the second time this year, now projecting 50,000 units shipped in 2026, nearly double its prior estimate of 28,000 and more than triple its January projection of 14,000. The investment bank estimates China’s humanoid robot market will hit $2 billion this year and scale to $15 billion by 2030.

China remains the dominant force in the robotics market. Barclays’ report noted that China installs roughly half of all industrial robots globally and accounted for 85% of humanoid robot installations last year, producing machines at nearly half the cost of Western competitors. Wedbush Securities’ Dan Ives told CNBC on June 3 that China is “right now the clear leader,” with the U.S. in “catch-up mode.”

Scaling the technology remains a formidable challenge. Reuters Breakingviews reported on June 11 that Unitree Robotics, the world’s largest humanoid maker by sales last year, saw first-quarter adjusted net profit fall 53% year-over-year even as sales rose 68%, with the company attributing the squeeze to rising R&D costs and price cuts as new rivals crowd in.

The IPO pipeline reinforces that point: at least 46 robotics companies are queued for listings in Hong Kong alone, and China has over 450,000 registered companies in the sector, according to state media. With technology still maturing, and even advanced models currently lacking the dexterity for basic tasks outside controlled environments, and competition intensifying across the board, the path from promise to profit remains anything but straightforward.

With that industry overview in mind, here are the most promising robotics stocks now.

Our Methodology

For this article, we screened U.S.-listed robotics stocks from various ETFs, focusing on companies that build robots, supply components for robotic systems, offer robotics-as-a-service solutions, or develop AI and software platforms for autonomous applications. We then evaluated each stock’s upside potential and hedge fund ownership in Q1 2026, ranking the final list by upside potential (street-high). To assess hedge fund sentiment, we relied on Insider Monkey’s hedge fund database, which tracks over 1,000 elite hedge fund managers and their holdings as of Q1 2026.

Note: All data sourced on June 24, 2026.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).

8. PROCEPT BioRobotics Corporation (NASDAQ:PRCT)

Number of Hedge Fund Holders: 28

Upside Potential: 147.60%

With significant hedge fund interest and strong upside, PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the most promising robotics stocks.

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is building a clinical case for Aquablation that could redefine its addressable market, with two major prostate cancer study milestones drawing fresh analyst attention to the stock.

On May 28, 2026, PROCEPT BioRobotics Corporation (NASDAQ:PRCT) announced two milestones in its WATER IV prostate cancer clinical program.

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) completed enrollment in the WATER IV RP study, a randomized trial comparing Aquablation therapy to radical prostatectomy in 280 patients, the only FDA randomized study of its kind. Primary endpoint results are expected to be presented at the American Urological Association Annual Meeting in spring 2027.

Alongside that, PROCEPT BioRobotics Corporation (NASDAQ:PRCT) received FDA Investigational Device Exemption (IDE) approval for a second protocol, WATER IV AS, which will enroll up to 333 patients globally to evaluate Aquablation therapy versus active surveillance in men with Grade Group 1 and 2 prostate cancer. Patients in both studies will be followed for ten years, with assessments covering disease control and quality-of-life outcomes, including urinary, sexual, and overall function.

That clinical progress drew a bullish response from Wall Street.

On June 24, 2026, Evercore ISI analyst Vijay Kumar initiated coverage of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) with an “Outperform” rating and a $30 price target. Kumar cited Aquablation as having the best clinical evidence in the space and argued that a positive WATER IV trial outcome over the next 12 months could expand the total addressable market into prostate cancer while supporting multiple expansion for the stock.

Procept BioRobotics Corporation (NASDAQ:PRCT) is a commercial-stage surgical robotics company that develops transformative solutions in urology in the U.S. and internationally.

7. NVIDIA Corporation (NASDAQ:NVDA)

Number of Hedge Fund Holders: 275

Upside Potential: 150.00%

Given its significant hedge fund backing and attractive upside potential, NVIDIA Corporation (NASDAQ:NVDA) is one of the most promising robotics stocks.

NVIDIA Corporation (NASDAQ:NVDA) is extending its physical AI ambitions on two fronts simultaneously, pushing deeper into industrial robotics safety while advancing its push into agentic life sciences.

On June 23, 2026, NVIDIA Corporation (NASDAQ:NVDA) announced the NVIDIA BioNeMo Agent Toolkit, a platform that equips AI agents with domain-specific life sciences tools spanning protein structure prediction, molecular docking, generative chemistry, genomic analysis, and biomarker discovery.

The toolkit draws on more than a decade of NVIDIA life sciences libraries and is powered by NIM microservices, Parabricks, NeMo, and Nemotron technologies. More than 50 companies are already using it, including Anthropic, OpenAI, Lilly, and Natera, with collaborations also spanning scientific data platforms, lab automation companies, and AI-native biology firms.

NVIDIA Corporation (NASDAQ:NVDA) said the toolkit can compress virtual screening timelines from days to minutes and has already delivered 2x faster performance for protein design models like RosettaFold3 through a collaboration with the University of Washington’s Institute for Protein Design.

A day earlier, NVIDIA Corporation (NASDAQ:NVDA) announced NVIDIA Halos for Robotics, described as the industry’s first full-stack safety system for robotics and physical AI, drawing on more than 18,600 years of engineering experience in autonomous vehicle safety development. The system spans AI compute, safety software, sensor data, and an ANAB-accredited inspection lab for functional and AI safety certification.

Agility, whose humanoid robot Digit operates in facilities for Amazon, GXO, Schaeffler, and Motor Manufacturing Canada, is the first company to integrate NVIDIA Halos for Robotics into its safety architecture.

NVIDIA Corporation (NASDAQ:NVDA) is a fabless semiconductor and AI computing company that designs GPUs, AI accelerators, Application Programming Interfaces (APIs), and system-on-a-chip units. Through its CUDA ecosystem, the company enables industries ranging from autonomous vehicles to scientific research by advancing AI, accelerated computing, and data center infrastructure.

Page 1 of 2

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.